Baijin Life Science Holdings Limited (1466.HK) HKSE

0.52

+0.01(+1.96%)

Updated at December 24 11:53AM

Currency In HKD

Valuation

Market Cap468.68M
Enterprise Value520.84M
P/E Ratio49.68
PEG Ratio0.04
Price/Sales Ratio3.36
Price/Book Ratio2.85
Enterprise/Revenue3.59
Enterprise/EBITDA41.08

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.07
Operating Margin-0.12

Management Effectiveness

Return On Assets0.03
Return On Equity0.06

Income Statement

Revenue135.56M
Revenue/Share0.16
Gross Profit41.99M
EBITDA6.26M
Net Income-316,000
Diluted EPS-0

Balance Sheet

Total Cash57.46M
Total Cash/Share0.07
Total Debt85.43M
Total Debt/Equity0.61
Current Ratio4.21
Book Value Per Share0.2

Price History

52-Week Change-11.86
52-Week High0.76
52-Week Low0.4
Moving Average 50 Days0.55
Moving Average 200 Days0.62

Statistics

Average Volume384,552
Shares Outstanding773.37M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor61:58
Last Split DateApril 06, 2022